Unlocking ferulic acid for neurological diseases and tailoring of nanoformulations to advance its brain delivery
- 16 September 2025
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 684, 126173
Abstract
No abstract availableKeywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 302 references indexed in Scilit:
- Glioblastoma and Other Primary Brain Malignancies in AdultsJAMA, 2023
- Iron and oxidizing species in oxidative stress and Alzheimer's diseaseAging Medicine, 2019
- Regulating Nanomedicine at the Food and Drug AdministrationAMA Journal of Ethics, 2019
- Cause and prevention of demyelination in a model multiple sclerosis lesionAnnals of Neurology, 2016
- Phenolic acids from malt are efficient acetylcholinesterase and butyrylcholinesterase inhibitorsJournal of the Institute of Brewing, 2012
- Analysis of 2,2’-Azobis (2-Amidinopropane) Dihydrochloride Degradation and Hydrolysis in Aqueous SolutionsJournal of Pharmaceutical Sciences, 2011
- Proteomic analysis of protein oxidation in Alzheimer's disease brainElectrophoresis, 2002
- Lymphocyte Oxidative DNA Damage and Plasma Antioxidants in Alzheimer DiseaseArchives of Neurology, 2002
- Neuropathology of synuclein aggregatesJournal of Neuroscience Research, 2000
- Mittheilungen aus dem chemischen Laboratorium in Innsbruck I)Ueber einige Harze [Zersetzungsproducte derselben durch schmelzendes Kali]European Journal of Organic Chemistry, 1866